MedTrace Logo

The European Tinnitus Survey: a Study on Tinnitus Prevalence in 12 European Countries

NCT04892095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11427

Last updated 2021-05-19

No results posted yet for this study

Summary

A European cross-sectional study was conducted with the aims of: i) examining inter-country differences in prevalence of tinnitus by comparing prevalence estimates in countries with relatively low versus high gross domestic product (GDP) per capita and comparing prevalence estimates in countries within different European regions (i.e., Northern, Southern, Eastern and Western Europe); ii) understanding the effect of sex, age, socio-economic variables, body mass index (BMI), and marital status on overall prevalence of tinnitus; iii) assessing the effect of hearing difficulty on tinnitus prevalence; and iv) exploring the effect of tinnitus severity on use of healthcare resource for tinnitus Overall, approximately 12,000 individuals aged 18 years or over are enrolled in 12 different European countries (BG, DE, ES, FR, GR, IE, IT, LV, PL, PT, RO, UK). Survey sample from each country were representative of the country-specific population in terms of sex, age, and socio-economic characteristics.

Conditions

  • Tinnitus

Interventions

OTHER

No intervention

This is an observational cross-sectional study. No intervention is considered.

Sponsors & Collaborators

  • University of Nottingham

    collaborator OTHER

  • University of Regensburg

    collaborator OTHER

  • Mario Negri Institute for Pharmacological Research

    lead OTHER

Principal Investigators

  • Silvano Gallus, ScD · Istituto Di Ricerche Farmacologiche Mario Negri

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-10-30
Completion
2018-10-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04892095 on ClinicalTrials.gov